Dried plasma for treating bleeding and urgent procedures
Part of Heart & circulation clinical trials.
This trial tests a dried (lyophilized) form of blood plasma that can be mixed with water and given to patients who need plasma transfusions. The goal is to see if this dried plasma is safe and works as well as frozen plasma for treating bleeding or reversing the effects of blood thinners like warfarin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be 18 years or older
- Must need a plasma transfusion for bleeding, before surgery, or to reverse the blood-thinning effect of warfarin
- Must not have received any plasma product in the 3 days before the study transfusion
- Must not have a known intolerance or allergy to plasma or its ingredients (like citrate)
- Must not be pregnant
- Must not need ECMO or TTP treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a dried form of blood plasma (called dry plasma) to people with severe bleeding in an ambulance or at the scene helps save lives. The dried plasma is mixed with water and given through an IV, and it may help stop bleeding better than just fluids alone.
This trial tests whether giving fresh frozen plasma (a blood product) soon after a traumatic brain injury can help people recover better. It is for adults aged 18 to 65 with moderate to severe TBI confirmed by CT scan.
This trial tests whether filtering your blood with a special device soon after a stroke clot is removed can improve recovery. It is for people who have had a large vessel stroke in the front part of the brain and have had a successful clot removal procedure.
This study tests a special plasma treatment (a part of your blood that may help healing) for many types of wounds. It aims to see if this treatment helps wounds close faster and better than standard care.
This trial compares two treatments for bleeding after heart surgery: a medicine called FEIBA (which helps blood clot) and fresh frozen plasma (a blood product). The goal is to see which works better as a first treatment for bleeding during recovery.
This trial tests whether a medication called recombinant von Willebrand factor (vWF) can help control major bleeding in adults who are on life support with ECMO. If you are on ECMO and have a serious bleed, this treatment might help stop the bleeding.
Hear when a new Thromboembolic Event trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.